Planned enrollment increased by 25 participants
Before: 35 participants (planned). After: 60 participants (planned).
Primary completion date changed
Before: Oct 2024. After: 31 Dec 2027.
Study sponsor: Supernus Pharmaceuticals, Inc. · SUPN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 35 participants (planned). After: 60 participants (planned).
Before: Oct 2024. After: 31 Dec 2027.